< 回列表
Young Saing Kim
- Professor, Gil Medical Center, Gachon University College of Medicine, South Korea
Balancing the Benefits and Risks of Adjuvant Therapy Across Different Cancer Types
| 角色 | 講師 |
| 日期時間 | 05/02 14:20 - 15:00 |
| 地點 | 701A |
學歷 / 訓練
2004, M.D., Gachon University College of Medicine, Incheon, South Korea
2009, M.S., Gachon University Graduate School, Incheon, South Korea
2017, PhD., Gachon University Graduate School, Incheon, South Korea
專業與研究經歷
2005 - 2009, Residency, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
2012 - 2013, Fellowship, Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
2015 - Present, Professor, Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
2021 - 2022, Visiting Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
獲獎與榮譽
2008
Young Investigator Travel Award, Korean Society of Medical Oncology (KSMO)
2018
Best Poster Award, ESMO Asia 2018 Congress
2025
Outstanding Paper Award, Korean Cancer Study Group (KCSG)
重要出版品
- Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-06)
- A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities.
- Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
- The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.
- Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.